George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 75.00
Bid: 70.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 10.00 (14.286%)
Open: 75.00
High: 75.00
Low: 75.00
Prev. Close: 75.00
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

30 Nov 2020 12:20

RNS Number : 9464G
Fiske PLC
30 November 2020
 

 

 

 

Fiske Plc

 

Issue of Equity

 

30 November 2020

 

Fiske plc ('Fiske' or 'the Company') today announces that further to the acquisition of Fieldings Investment Management Ltd ("Fieldings") announced on 27 July 2017, the third and final deferred consideration payment due to the vendors of Fieldings will be £198,480 (the "Final Deferred Consideration"). In accordance with the agreement, 20 per cent. of the Final Deferred Consideration is payable in ordinary shares of 25p each in the Company ("Ordinary Shares") issued at the average closing price of the 15 business days prior to allotment. The Company has therefore issued 61,069 Ordinary Shares at a price of 65.0p each.

 

Application has been made for these new Ordinary Shares to be admitted to trading on AIM with admission expected to take place on, or around, 4 December 2020 ("Admission").

 

Following Admission, the Company's enlarged share capital will comprise 11,754,859 Ordinary Shares. No shares are held in Treasury. Therefore, the total number of Ordinary Shares with voting rights is 11,754,859. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

3,826 Ordinary Shares will be issued to Tony Pattison, Director of the Company and previously a shareholder of Fieldings. Following the issue of these new shares, Mr Pattison will hold 349,617 Ordinary Shares representing 2.97 per cent. of the Company's total voting rights. The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

The information communicated in this announcement constitutes inside information for the purposes of Article 7 of Regulation 596/2014. Following publication of this announcement this information is considered to be in the public domain.

 

For further information please contact:

 

Samantha Harrison, Harrison Clarke - Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

 

James Harrison, Fiske Plc - CEO

(tel: 020 7448 4700)

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Tony Pattison

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Fiske Plc

b)

 

LEI

 

 

213800Z5PKJOV7GWXE43

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 25 pence each

Identification code

FISK

b)

 

Nature of the transaction

 

 

Issue of shares

c)

 

Price(s) and volume(s)

Price(s) £0.65

Volume(s) 3,826

d)

 

Aggregated information

- Aggregated volume

- Price

e)

 

Date of the transaction

 

 

30/11/2020

f)

 

Place of the transaction

 

 

Outside of trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFLFLFLTLIVII
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.